Recurrent infection & exposure-led infectious care
Choose investigations that fit the symptom pattern, exposure history and immune context.
The clinical question
An isolated antibody or molecular result does not establish persistent illness; no laser-based eradication is offered.
What to discuss next
Ask about the specific indication, intended scope, responsible clinician or laboratory, and the availability of the pathway. The team must confirm arrangements before care or testing can be planned.
These linked method descriptions explain their specimen, analytical scope and limits. The status of a method and the availability of a service are separate considerations.
uti-molecular / Molecular diagnostics
Selected UTI molecular panel
Planned
A planned assay for specified organisms in a validated urine matrix—not a replacement for clinical assessment.
Question
Could a targeted molecular result contribute to a symptomatic urinary evaluation?
Specimen
Validated urine specimen and transport medium, to be released
Preparation
Collection method, symptoms and recent antimicrobial exposure must be documented according to the approved workflow.
Platform
Targeted nucleic-acid amplification; panel and controls pending
Analytical scope
Assay-defined microbial nucleic-acid targets
Interpretation limits
A positive molecular signal does not by itself establish clinically significant infection; the chosen panel cannot detect organisms it does not target.
sexual-health-molecular / Molecular diagnostics
Women’s health & STI molecular pathways
Planned
Separate, clinician-directed tests selected for the actual question rather than a mandatory bundled panel.
Question
Which targeted infection test is appropriate for the clinical presentation and specimen site?
Specimen
Assay-specific urine or swab type and anatomic site
Preparation
The correct collection kit, specimen site and timing are method-specific and will be supplied with the approved test.
Platform
Targeted nucleic-acid amplification
Analytical scope
Specified pathogen targets according to the released assay
Interpretation limits
Different assays and specimen sites have different validated uses. A negative result outside the appropriate collection context may not resolve the question.